JP2021519305A5 - - Google Patents

Info

Publication number
JP2021519305A5
JP2021519305A5 JP2020551882A JP2020551882A JP2021519305A5 JP 2021519305 A5 JP2021519305 A5 JP 2021519305A5 JP 2020551882 A JP2020551882 A JP 2020551882A JP 2020551882 A JP2020551882 A JP 2020551882A JP 2021519305 A5 JP2021519305 A5 JP 2021519305A5
Authority
JP
Japan
Prior art keywords
seq
polypeptide
antigen
amino acid
acid sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2020551882A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021519305A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/024052 external-priority patent/WO2019191079A1/en
Publication of JP2021519305A publication Critical patent/JP2021519305A/ja
Publication of JP2021519305A5 publication Critical patent/JP2021519305A5/ja
Pending legal-status Critical Current

Links

JP2020551882A 2018-03-26 2019-03-26 肝臓およびリンパ節の類洞内皮細胞Ｃ型レクチン（ＬＳＥＣｔｉｎ）を標的とするための方法および組成物 Pending JP2021519305A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862647911P 2018-03-26 2018-03-26
US62/647,911 2018-03-26
PCT/US2019/024052 WO2019191079A1 (en) 2018-03-26 2019-03-26 Methods and compositions for targeting liver and lymph node sinusoidal endothelial cell c-type lectin (lsectin)

Publications (2)

Publication Number Publication Date
JP2021519305A JP2021519305A (ja) 2021-08-10
JP2021519305A5 true JP2021519305A5 (https=) 2022-04-01

Family

ID=68060405

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020551882A Pending JP2021519305A (ja) 2018-03-26 2019-03-26 肝臓およびリンパ節の類洞内皮細胞Ｃ型レクチン（ＬＳＥＣｔｉｎ）を標的とするための方法および組成物

Country Status (4)

Country Link
US (1) US20210171642A1 (https=)
EP (1) EP3774890A4 (https=)
JP (1) JP2021519305A (https=)
WO (1) WO2019191079A1 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9850296B2 (en) 2010-08-10 2017-12-26 Ecole Polytechnique Federale De Lausanne (Epfl) Erythrocyte-binding therapeutics
EP2603520A4 (en) 2010-08-10 2014-02-19 Ecole Polytech ERYTHROCYTE BINDING THERAPEUTICS
US9517257B2 (en) 2010-08-10 2016-12-13 Ecole Polytechnique Federale De Lausanne (Epfl) Erythrocyte-binding therapeutics
US10953101B2 (en) 2014-02-21 2021-03-23 École Polytechnique Fédérale De Lausanne (Epfl) Glycotargeting therapeutics
SG11201606761RA (en) 2014-02-21 2016-09-29 Ecole Polytecnique Federale De Lausanne Epfl Epfl Tto Glycotargeting therapeutics
US10046056B2 (en) 2014-02-21 2018-08-14 École Polytechnique Fédérale De Lausanne (Epfl) Glycotargeting therapeutics
US10946079B2 (en) 2014-02-21 2021-03-16 Ecole Polytechnique Federale De Lausanne Glycotargeting therapeutics
WO2018232176A1 (en) 2017-06-16 2018-12-20 The University Of Chicago Compositions and methods for inducing immune tolerance
EP3790577A4 (en) 2018-05-09 2022-04-27 The University of Chicago COMPOSITIONS AND METHODS RELATED TO IMMUNTOLERANCE
CN113710229B (zh) 2019-02-25 2026-01-06 芝加哥大学 用与抗炎剂连接的ecm亲和肽治疗炎症性和自身免疫性病症的方法和组合物
CN119053624A (zh) * 2022-02-18 2024-11-29 芝加哥大学 生长激素受体靶向多肽

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008019366A2 (en) * 2006-08-07 2008-02-14 Ludwig Institute For Cancer Research Methods and compositions for increased priming of t-cells through cross-presentation of exogenous antigens
TW200846363A (en) * 2007-03-22 2008-12-01 Urrma R & B Novel human anti-R7V antibodies and uses thereof
CA2719718C (en) * 2008-03-28 2019-07-02 Mdna Life Sciences Inc. Aberrant mitochondrial dna, associated fusion transcripts and hybridization probes therefor
US10294294B2 (en) * 2015-09-10 2019-05-21 Albert Einstein College Of Medicine Synthetic antibodies to BAX and uses thereof

Similar Documents

Publication Publication Date Title
JP2021519305A5 (https=)
JP7840836B2 (ja) 改善された血清アルブミン結合性免疫グロブリン可変ドメイン
JP7453206B2 (ja) 改良された血清アルブミン結合剤
JP2021191763A5 (https=)
JP2020522261A5 (https=)
JP2021503455A5 (https=)
JP2021510710A5 (https=)
JP2022545196A5 (https=)
JP2006020633A (ja) 糸球体腎炎および他の炎症性疾患の治療のための組成物および方法
JP2011509245A5 (https=)
JP2010536384A5 (https=)
RU2015136078A (ru) Антитело против с5 и способ предупреждения и лечения обусловленных комплементом заболеваний
RU2765878C2 (ru) Антитела для лечения инфекции гепатитом в и связанных с ней заболеваний
KR20130137584A (ko) 수동 인플루엔자 면역에 유용한 항체
JP7743406B2 (ja) 抗ｂｃｍａ ｃａｒ抗体、コンジュゲートおよび使用方法
JP2019507580A5 (https=)
JP2017507131A5 (https=)
JP2019504615A5 (https=)
JP2024001073A5 (https=)
JPWO2020059847A5 (https=)
JP2021511387A5 (https=)
JP2025510642A5 (https=)
JP2018531625A5 (https=)
JP2025130076A5 (https=)
JP2015525075A (ja) Ｃａ２１５に対するヒト化抗体